4
Changes in Ownership
BioAge Labs, Inc. Filed Acc 0001415889-24-024047
Director bought 900,000 shares at $18.00 ($16,200,000)
- Director acquired 2,113,975 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Pande Vijay Satyanand · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-27 | Conversion : show line 1 in the form | +855,972 | 855,972 | I | ||
| 2024-09-27 | Conversion : show line 2 in the form | +413,100 | 1,269,072 | I | ||
| 2024-09-27 | Conversion : show line 3 in the form | +189,609 | 189,609 | I | ||
| 2024-09-27 | Conversion : show line 4 in the form | +655,294 | 655,294 | I | ||
| 2024-09-27 | Purchase : show line 5 in the form | +900,000 | $18.00 | $16,200,000 | 900,000 | I |
| Open-market purchases · 900,000 sh · avg $18.00 · $16,200,000 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-27 | Conversion : show line 6 in the form Series A-1 Preferred Stock | −3,819,863 | 0 | I |
| 2024-09-27 | Conversion : show line 7 in the form Series B Preferred Stock | −1,843,502 | 0 | I |
| 2024-09-27 | Conversion : show line 8 in the form Series C Preferred Stock | −846,152 | 0 | I |
| 2024-09-27 | Conversion : show line 9 in the form Series D Preferred Stock | −2,924,318 | 0 | I |
Loading xslF345X05/form4-09272024_080956.xml…